Meridian Bioscience
Drew Eagan is a financial professional with over four years of experience in diverse roles across financial analysis, investment strategy, and wealth management. Currently serving as a Senior Financial Analyst in Global FP&A at Meridian Bioscience Inc. since April 2023, Drew excels in generating data-driven financial insights and supporting strategic budgeting and forecasting. Prior experience includes positions as an Investment Strategy Associate at Constellation Wealth Advisors and a Wealth Strategy Associate at UBS, where support was provided to ultra-high net worth clients. Drew's earlier roles involved internships at U.S. Bank, Fifth Third Bank, Phillips Edison & Company, and Foster & Motley, focusing on capital markets, wealth management, underwriting, and tax preparation. Currently pursuing an MBA at Xavier University, Drew holds a BBA in Finance and Information Systems from the University of Cincinnati.
This person is not in any teams
Meridian Bioscience
1 followers
Meridian Bioscience Inc. products are designed to enhance patient well-being while reducing the total outcome costs of healthcare.